Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 50268-585

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 50268-585). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 (585 15 20mg)

20 (585 15 20mg)
This is a description of a medication with the NDC code 50268-565-15, which is Pantoprazole Sodium Delayed-Release Tablets, USP. It comes in a unit dose of 50 tablets, with each tablet containing 1020g panoprazle. The usual dosage instructions are not provided and must be obtained elsewhere. The medication should not be chewed or crushed before administration. It should be stored at a temperature of 20° to 25°C with permitted excursions of 15° to 30°C. The manufacturer is AKARE.*
FDA Label Image

Chemical Structure (Pantoprazole Sodium Delayed Release Tablets 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.